Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 1475 entries
View as:

A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06955741 Org: User:
Start: 05/05/25 End: 08/04/25 Due: 08/04/26

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03704077 Org: User:
Start: 10/31/19 End: 09/30/24 Due: 09/30/25

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)

Phase: N/A Priority: Normal
NCT ID: NCT00874770 Org: User:
Start: 06/30/09 End: 01/31/11 Due: 01/31/12

Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03362437 Org: User:
Start: 11/15/17 End: 12/28/17 Due: 12/28/18

A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05362045 Org: User:
Start: 05/16/22 End: 08/19/22 Due: 08/19/23

Drug-Drug Interaction Study With Rifampin

Phase: N/A Priority: Normal
NCT ID: NCT01002079 Org: User:
Start: 08/31/10 End: 10/31/10 Due: 10/31/11

The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00655746 Org: User:
Start: 04/30/08 End: 05/31/08 Due: 05/31/09

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care in Japanese Patients (Pegylated-interferon Alpha-2a and Ribavirin)

Phase: N/A Priority: Normal
NCT ID: NCT01017575 Org: User:
Start: 12/31/09 End: 10/31/11 Due: 10/31/12

Hepatic Impaired Subjects Compared to Healthy Subjects Receiving Multi-dose BMS-650032

Phase: N/A Priority: Normal
NCT ID: NCT01019070 Org: User:
Start: 12/31/09 End: 08/31/11 Due: 08/31/12

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00527735 Org: User:
Start: 02/29/08 End: 12/31/11 Due: 12/31/12

Phase IIB Pilot of Atazanavir + Raltegravir

Phase: N/A Priority: Normal
NCT ID: NCT00768989 Org: User:
Start: 11/30/08 End: 05/31/10 Due: 05/31/11

Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01754974 Org: User:
Start: 03/31/13 End: 09/30/14 Due: 09/30/15

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00162253 Org: User:
Start: 04/30/05 End: - Due: -

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05730725 Org: User:
Start: 04/03/23 End: 08/06/24 Due: 08/06/25

Participant Reported Outcomes and Treatment Experiences in Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04472663 Org: User:
Start: 07/06/20 End: 12/09/20 Due: 12/09/21

A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05407675 Org: User:
Start: 08/02/22 End: 10/14/25 Due: 10/14/26

A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01718145 Org: User:
Start: 11/30/12 End: 12/31/14 Due: 12/31/15

Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00103844 Org: User:
Start: 02/28/05 End: 03/31/08 Due: 03/31/09

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05827016 Org: User:
Start: 06/22/23 End: 01/01/36 Due: 01/01/37

A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00461110 Org: User:
Start: 01/31/08 End: 04/30/09 Due: 04/30/10

Long-term Experience With Abatacept SC in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT02090556 Org: User:
Start: 03/26/13 End: 01/29/19 Due: 01/29/20

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Phase: N/A Priority: Normal
NCT ID: NCT00633789 Org: User:
Start: 06/30/08 End: 12/31/12 Due: 12/31/13

A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00002177 Org: User:
Start: 05/31/97 End: 03/31/00 Due: 03/31/01

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT02741570 Org: User:
Start: 10/05/16 End: 09/22/22 Due: 09/22/23

A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT02413372 Org: User:
Start: 05/08/15 End: 06/19/17 Due: 06/19/18